1 week ago
76
Pharming Group (AMS:PHARM) Full Year 2022 Results
Key Financial Results
Revenue: US$205.6m (up 3.4% from FY 2021).
Net income: US$13.7m (down 14% from FY 2021).
Profit margin: 6.7% (down from 8.0% in FY 2021). The decrease in margin was driven by higher expenses.
EPS: US$0.021 (down from US$0.025 in FY 2021).
